DISCOVER
CORPORATE NEWS
2025 - PR Telemedicine Technologies and Micron Join Forces Under the CRO Alliance 2024 - PR TTelemedicine Technologies & Artialis partner for clinical research innovation - PR Telemedicine Technologies wins BSMA Clinical Trials Supply Chain Award for groundbreaking CleanWeb™-RTSM module - PR Revenues 2023 2023 - PR VisionHM listed at UGAP - PR acquisition of the French start-up CTMA - PR FY2023 Q1 results - PR FY2023 Q2 results - PR TTSA joins 40-Partner Consortium in xShare Initiative 2022 - PR acquisition of the Swiss company DAPSYS - PR BSA AIR - PR new facilities in Laval, France - PR new facilities in Liège, Belgium - PR FY2022 results 2021 - PR acquisition of the Belgian eCRO Lambda-Plus - PR VisionHM listed at UniHA
Contact
Investors relation
OUR STORY,
OUR STRENGTH
Telemedicine Technologies is the publisher of e-Health solutions, market leader in the field of Clinical Research with its CleanWeb™ solution, a secure Internet platform dedicated to the electronic management of clinical trials and registries.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
April 29, 2025
May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]
April 29, 2025
Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]
April 29, 2025
Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]